Stay updated on Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    An NIH grant/contract funding note was added to the study's identifiers, clarifying the funding source behind the trial. This addition provides funding transparency but does not alter study design, endpoints, or participant information.
    Difference
    0.1%
    Check dated 2026-08-24T18:06:07.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision badge updated from v3.6.4 to v3.6.5, indicating a minor platform release. The update does not alter study details or visible content on the page.
    Difference
    0.0%
    Check dated 2026-08-10T13:01:17.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 tag was added and several unrelated topics/links along with an older Revision tag were removed, indicating a metadata cleanup rather than changes to the trial data.
    Difference
    0.2%
    Check dated 2026-07-27T06:19:31.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added related topics: Lung cancer, related topics, and MedlinePlus Genetics to the study record, improving contextual linkage to related resources. The change enhances navigation and discoverability without altering the study's content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-12T20:21:51.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.3' was added to the site's revision log, while older items including 'Lung cancer', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.6.2' were removed.
    Difference
    0.2%
    Check dated 2026-07-05T13:27:26.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Added Lung cancer and related topics with a MedlinePlus Genetics link to the page's information section. The revision tag was updated to v3.6.2, replacing the previous v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-28T08:16:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.